Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
Holland
Gary N
GN
Ocular Inflammatory Disease Center, Jules Stein Eye Institute, and Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-7003, USA. uveitis@jsei.ucla.edu
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006801:Humans; D011446:Prospective Studies; D011739:Pyrimethamine / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013411:Sulfadiazine / Q000627:therapeutic use*; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D013411:Sulfadiazine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011739:Pyrimethamine